San Diego’s Biotech Boom Meets a Pause

San Diego has long stood as one of the nation’s premier biotech hubs, trailing only Boston and the Bay Area in its concentration of startups, research institutes, and specialized lab space. But in recent months, the industry has faced turbulence. A wave of biotech layoffs, reduced venture funding, and cautious investors are reshaping the region’s once-hot market.

For the first time in years, San Diego’s lab space market — once defined by scarcity and premium pricing — is seeing a measurable rise in vacancies. This shift is creating new challenges for property owners while opening fresh opportunities for tenants looking to secure space.

Layoffs, Funding Pressure, and Rising Vacancies

Throughout 2024 and 2025, many biotech companies that expanded aggressively are now downsizing. Venture capital has tightened, IPO windows have narrowed, and risk appetite has cooled. These factors have led to workforce reductions across the sector.

At the same time, the ripple effect is hitting real estate. Labs that were previously in high demand are now sitting empty. Developers that raced to build new life science campuses must adapt to a slower leasing environment, while existing landlords face increased pressure to offer concessions.

What This Means for Lab Space

For Tenants

• More Negotiating Power: Companies now have leverage to negotiate lower rents, shorter lease terms, or enhanced tenant improvements.

• Wider Choice: With vacancies rising, startups can access prime locations that were previously out of reach.

• Flexible Space Models: Interest in shared labs, plug-and-play suites, and modular layouts is growing as tenants seek to reduce risk.

For Landlords & Developers

• Rising Vacancy Pressure: Holding empty space longer than expected puts pressure on operating budgets and debt.

• Need for Differentiation: Buildings with strong amenities, adaptable layouts, and competitive pricing will capture more demand.

• Potential for Repositioning: Underutilized space could be converted into shared labs, contract research facilities, or biomanufacturing suites.

Sub-Market Dynamics in San Diego

Not all areas are equally affected. Core sub-markets such as Torrey Pines, Sorrento Mesa, and UTC continue to benefit from proximity to UCSD, Scripps, and established biotech clusters. However, more peripheral markets are seeing sharper rises in vacancy.

This means location and ecosystem connectivity still matter — companies remain willing to pay premiums for access to talent and research networks, while secondary areas may need to compete more heavily on price.

Opportunities in the Slowdown

While the headlines focus on layoffs, the current slowdown also creates unique opportunities:

• Startups & Growing Biotechs: This is one of the best times in recent years to lock in favorable lease terms and secure high-quality lab space.

• Investors: With valuations softening, there’s a chance to acquire well-located lab assets at more attractive entry points.

• Landlords: Creative leasing — such as short-term agreements, shared infrastructure, or turnkey spaces — can attract tenants who might otherwise hesitate to commit.

What to Watch Going Forward

Despite short-term headwinds, the fundamentals that made San Diego a biotech powerhouse remain intact: world-class universities, a deep talent pool, and a strong culture of innovation. Signs of recovery could come from renewed venture capital flows, biotech stock rebounds, and new research breakthroughs that reignite industry growth.

For now, the lab space market is in transition — shifting from a landlord-driven environment to one where tenants hold more influence. Stakeholders who adapt quickly, stay flexible, and plan strategically will be best positioned for the next cycle of growth.